ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Cancer

August 22, 2019
This study of over 25,000 pts from the International Lung Cancer Consortium identified underweight and severly obese patients as having poorer survival than others, whereas a survival advantage was evident among patients who were overweight or mildly obese.  Decreased BMI (wt loss) was associated with poorer outcomes across all BMI categories.
August 21, 2019
An interesting discussion in this manuscript of a case-control study of 666 subjects.
August 20, 2019
Interesting follow-up study of 208 pulmonary ground -glass opacities in 160 subjects, with a yield of three adenocardinomas.
August 15, 2019
Using a machine learning algorithm, resource utilization among more than 1 million Medicare patients undergoing one of 6 operations including CABG and lung resection was analyzed.  Super users comprised 4.8% of the cohort but consumed 31.7% of the resources.  Risk factors for super use included paraplegia/hemiplegia, weight loss, and CHF combined wit
August 15, 2019
Regionalization of care for complex problems remains an open question in most countries. This review demonstrated that, for high risk cancer operations in the US, the Leapfrog group's volume standards did not differentiate between surgical mortality outcomes for lung and esophageal cancer surgery.
August 8, 2019
A detailed and robust meta-analysis asserting lack of strong evidence supporting either modality.
August 8, 2019
Sridhar Rathinam of Glenfield Hospital in Leicester, United Kingdom, discusses surgical approaches for pulmonary neuroendocrine tumors.
August 5, 2019
Ng and colleagues evaluated 145 studies in order to provide evidence-based statements on the optimal approach for lobectomy for non–small cell lung cancer, comparing thoracotomy, multiport video-assisted thoracic surgery (VATS), robotic VATS, and uniportal VATS.
August 1, 2019
Filmed at the 2019 STS Annual Meeting in San Diego, California, Mara Antonoff of the MD Anderson Cancer Center moderates a discussion on how immunotherapy is changing the landscape of surgical lung cancer care.
July 29, 2019
Beckers and colleagues evaluated toxicity and outcomes of regional chemotherapeutic treatment with isolated lung perfusion of melphalan combined with metastasectomy for patients with resectable pulmonary metastases. The prospective study included 107 patients with metastases of colorectal carcinoma, osteosarcoma, or soft-tissue sarcoma.

Pages